logo

DoD Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award

Sector: Hospital • Location: United States of America

Source: Grants.gov

Project
Archived

As the vision of the FY09 ALSRP is to improve treatments for ALS, the Therapeutic Development Award is being offered to support preclinical development of therapeutics for amyotrophic lateral sclerosis (ALS). Investigators are encouraged to undertake preclinical studies of novel and existing agents. The Therapeutic Development Award is restricted to research in ALS. The proposed studies are expect

Project Information FAQ

Project Information

5 Q
The project “DoD Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

archived

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

As the vision of the FY09 ALSRP is to improve treatments for ALS, the Therapeutic Development Award is being offered to support preclinical development of therapeutics for amyotrophic lateral sclerosis (ALS). Investigators are encouraged to undertake preclinical studies of novel and existing agents. The Therapeutic Development Award is restricted to research in ALS. The proposed studies are expected to be empirical in nature and product-driven, but may have a hypothesis-driven approach, provided the focus is on therapeutics. It is anticipated that the agents and/or data generated from these awards will lead to the advancement of therapeutics for ALS. Studies focused on basic science research that will not directly inform therapeutic development do not meet the intent of the award mechanism. Additionally, clinical trials will not be allowed.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data